Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Micafungin During CVVHDF
NCT02651038Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- May 2012
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of micafungin in candida sepsis and candidiasis, sponsored by Medical University of Vienna. Primary endpoint: Haemofiltration clearance of Micafungin at 49 hours. Started May 2012; status: completed.
02
Drugs
micafungin
03
Conditions
candida sepsiscandidiasis
Beyond the preview
Go deeper on NCT02651038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02651038.